StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$27.93−0.08 (-0.29%)

Close on Nov 16, 2026Market cap $1.82BP/E –Yield –

Zenas BioPharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Zenas BioPharma's enterprise value was $1.37B on Nov 11, 2026, against $1.41B a year earlier. Over the last 2 years it ranged from -$57.83M to $1.60B, with a median of $622.99M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.37B+4.8%
2025Dec 31, 2025$1.30B–
2024Dec 31, 2024-$44.61M–

More Zenas BioPharma figures

See a number that looks wrong?